Michael J. Detke
Corporate Officer/Principal bei Indiana University
Profil
Michael J.
Detke is the founder of Detke Biopharma Consulting LLC, which was founded in 2013.
He held the title of President from 2013 to 2018.
Currently, he is a Professor at Indiana University.
Dr. Detke's former jobs include Executive Director at Eli Lilly & Co. and Lilly Research Laboratories, Director & Chief Medical Officer at Medavante Research Institute, Chief Medical Officer at MedAvante, Inc., Head-Early Phase Development at CNS Therapeutics, Inc., and Chief Medical Officer at CoMentis, Inc. He held the title of Chief Medical Officer at Embera NeuroTherapeutics, Inc. from 2016 to 2018 and at Quince Therapeutics, Inc. from 2018 to 2022.
Dr. Detke's education history includes a graduate and doctorate degree from the University of Pennsylvania and undergraduate and graduate degrees from Yale University.
Aktive Positionen von Michael J. Detke
| Unternehmen | Position | Beginn |
|---|---|---|
| Indiana University | Corporate Officer/Principal | 03.02.2010 |
Ehemalige bekannte Positionen von Michael J. Detke
| Unternehmen | Position | Ende |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 02.05.2022 |
Embera NeuroTherapeutics, Inc.
 Embera NeuroTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Embera NeuroTherapeutics, Inc. develops treatments for smoking cessation, cocaine dependence and other addictions. The company was founded by Nicholas Edward Goeders and Marie A. Lindner in 2005 and is headquartered in Sudbury, MA. | Chief Tech/Sci/R&D Officer | 01.12.2018 |
| Detke Biopharma Consulting LLC | Founder | 01.12.2018 |
CoMentis, Inc.
 CoMentis, Inc. Pharmaceuticals: MajorHealth Technology CoMentis, Inc. focuses on developing drugs to treat various central nervous system disorders. Its research and development spectrum include BACE inhibitors and modulators of the a7 nicotinic acetylcholine receptor (NAChR). The company was founded by John P. Cooke and Muralitharan Kengatharan in 2006 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01.12.2018 |
| ELI LILLY AND COMPANY | Director/Board Member | - |
Ausbildung von Michael J. Detke
| University of Pennsylvania | Doctorate Degree |
| Yale University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| QUINCE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
MedAvante, Inc.
 MedAvante, Inc. Packaged SoftwareTechnology Services MedAvante, Inc. provides signal detection solutions in clinical trials of treatments for central nervous system disorders. It offers Virgil investigative study platform for site-based assessments; and MedAvante central ratings for live assessments. The firm also offers scientific risk reduction services. The company was founded by Paul M. Gilbert, Amy Ellis, Peter B. Tilles, Livingston Johnson and Avik Roy in 2002 and is headquartered in Hamilton, NJ. | Technology Services |
Embera NeuroTherapeutics, Inc.
Embera NeuroTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Embera NeuroTherapeutics, Inc. develops treatments for smoking cessation, cocaine dependence and other addictions. The company was founded by Nicholas Edward Goeders and Marie A. Lindner in 2005 and is headquartered in Sudbury, MA. | Health Technology |
CNS Therapeutics, Inc.
 CNS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology CNS Therapeutics, Inc. develops and manufactures drug delivery products. The company was founded in 2007 and is headquartered in St. Paul, MN. | Health Technology |
CoMentis, Inc.
CoMentis, Inc. Pharmaceuticals: MajorHealth Technology CoMentis, Inc. focuses on developing drugs to treat various central nervous system disorders. Its research and development spectrum include BACE inhibitors and modulators of the a7 nicotinic acetylcholine receptor (NAChR). The company was founded by John P. Cooke and Muralitharan Kengatharan in 2006 and is headquartered in South San Francisco, CA. | Health Technology |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a private company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Commercial Services |
| Detke Biopharma Consulting LLC | |
| Medavante Research Institute |
